Cargando…
Aminoguanidines: New leads for treatment of Giardia duodenalis infection
Giardia duodenalis is an ubiquitous parasitic pathogen that causes significant morbidity and mortality worldwide. Failures in drug therapy are commonly due to poor patient compliance as a result of the need for repeated administration, off target drug effects and increasing parasite drug resistance....
Autores principales: | Abraham, Rebecca J., Abraham, Sam, Stevens, Andrew J., Page, Stephen W., McCluskey, Adam, Trott, Darren J., O'Handley, Ryan M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6479099/ https://www.ncbi.nlm.nih.gov/pubmed/31015151 http://dx.doi.org/10.1016/j.ijpddr.2019.04.003 |
Ejemplares similares
-
Antigiardial Activity of Novel Guanidine Compounds
por: Stevens, Andrew J., et al.
Publicado: (2022) -
Giardia duodenalis Virulence — “To Be, or Not To Be”
por: Argüello-García, Raúl, et al.
Publicado: (2021) -
The public health and clinical significance of Giardia and Cryptosporidium in domestic animals
por: Thompson, R.C. Andrew, et al.
Publicado: (2008) -
Thieno[3,2-b]pyrrole 5-carboxamides as potent and selective inhibitors of Giardia duodenalis
por: Hart, Christopher JS., et al.
Publicado: (2023) -
Identification of Zoonotic Genotypes of Giardia duodenalis
por: Sprong, Hein, et al.
Publicado: (2009)